Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

October 20, 2032

Study Completion Date

December 31, 2032

Conditions
Ischemic StrokeStrokeStroke, AcuteStroke, IschemicBrain DiseasesMajor Adverse Cardiovascular Event
Interventions
DIAGNOSTIC_TEST

Thrombus analyses

Physical, histology, biochemical or protein expressions of the thrombi obtained from thrombectomy procedures may contain information regarding the etiology of stroke and relevant disease pathology. The investigators shall store the thrombus, if any, yielded from thrombectomy procedures for future analyses.

DIAGNOSTIC_TEST

Imaging assessment

All imaging data will be deidentified before assessment. Plain computer tomography of the brain (CT brain), CT angiography (CTA), CT perfusion (CTP), magnetic resonance imaging of the brain (MRI), digital subtraction imaging (DSA) will be analysed. The investigators shall blind the assessors from treatment choice and outcome in all analyses that require human assessment.

Trial Locations (3)

266000

RECRUITING

The Affiliated Hospital of Medical College of Qingdao University, Qingdao

276000

RECRUITING

Linyi People's Hospital, Linyi

Unknown

RECRUITING

Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Linyi People's Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER